| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesia and General Intensive Care, University of Vienna and Ludwig Boltzmann Institute for Experimental Anesthesiology and Research in Intensive Care, Vienna, Austria
Abstract
To examine the effects of propofol on the function of normal, collateral-dependent, and acutely ischemic myocardium, nine mongrel dogs were chronically instrumented with hydraulic occluders and ameroid constrictors were inserted around the left coronary artery, pressure transducers in the left ventricle, and heparin-filled catheters in the descending aorta and the left atrium. Regional function of normal, collateral-dependent, and acutely ischemic myocardium was assessed by sonomicrometry. Propofol (5 mg/kg intravenously) reduced function in normal myocardium (-15% ± 5%, 1 min and –14% ± 5%, 3 min after injection) and in collateral-dependent myocardium (-14% ± 5% and –13% ± 5%) to similar degrees, whereas ischemic myocardial function deteriorated significantly more (-25% ± 10% and –23% ± 10%, P < 0.01). Although left ventricular end-diastolic pressure remained unchanged and left ventricular contractility was reduced (-16% ± 4%, 1 min and –15% ± 3%, 3 min after propofol, P < 0.01), significant increases in heart rate (35% ± 7% and 26% ± 7%, P < 0.01) and decreases in coronary perfusion pressure (-14% ± 5%, P < 0.05 and –19% ± 6%, P < 0.01) occurred, likely affecting the function of ischemic myocardium. Thus, whereas collateral-dependent myocardium tolerated these adverse hemodynamic effects, ischemic myocardium responded with impairment of regional function that was significantly more pronounced than the impairment which occurred in normal or collateral-dependent areas after a 5 mg/kg intravenous bolus of propofol.
This article has been cited by other articles:
![]() |
M. D. Banas, S. Baldwa, G. Suzuki, J. M. Canty Jr., and J. A. Fallavollita Determinants of contractile reserve in viable, chronically dysfunctional myocardium Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2791 - H2797. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. H. Lim, A. P. Halestrap, G. D. Angelini, and M.-S. Suleiman Propofol Is Cardioprotective in a Clinically Relevant Model of Normothermic Blood Cardioplegic Arrest and Cardiopulmonary Bypass Experimental Biology and Medicine, June 1, 2005; 230(6): 413 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mei{beta}ner, T. P. Weber, H. Van Aken, K. Zbieranek, and N. Rolf Recovery from Myocardial Stunning Is Faster with Desflurane Compared with Propofol in Chronically Instrumented Dogs Anesth. Analg., December 1, 2000; 91(6): 1333 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Javadov, K. H.H. Lim, P. M. Kerr, M.-S. Suleiman, G. D. Angelini, and A. P. Halestrap Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition Cardiovasc Res, January 14, 2000; 45(2): 360 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Wouters, M. Van de Velde, and J. Van Hemelrijck Cardiovascular Effects of Propofol Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 121 - 131. [PDF] |
||||
|